Biotech Fate Therapeutics TOP PICK

Fate Therapeutics: Revolutionizing Cellular Immunotherapies

Biotech News | 02.09.2020

Fate Therapeutics is a San Diego-based biopharmaceutical company researching and developing a novel...

Biotech News

Click Here to Get the FREE MAGAZINE

Biotech News | 30.08.2020

There are lots of great articles about the best biotech stocks to buy now in the free monthly...

Biotech Biotech Takeover Targets News

The Official Biotech Investments M&A Target List for 2020 and 2021

Biotech News | 27.08.2020

Most people investing in biotech stocks know that there are always lots of buyout rumors in the...

Biotech News Novocure

Novocure: +17% Since Our Initial Recommendation in the MAGAZINE Three Weeks Ago

Biotech News | 21.08.2020

Three weeks ago, we have presented the Amercian oncology company Novocure as a HOT STOCK in our...

Biotech Clovis Oncology News

Clovis Oncology: One of the Top Biotech Takeover Targets for a Merger and Acquisition in 2020 or 2021

Biotech News | 17.08.2020

Major merger and acquisition activities can be expected for the biotech industry for the rest of...

Biotech Idorisa Pharmaceuticals News

Idorsia Paves the Way Towards Its First Drug Approval: Daridorexant in Insomnia

Biotech News | 07.07.2020

The Swiss company Idorsia, one of the rising stars of the Swiss biotech scene and member of our...

Biotech News Radius Health

Is Radius Health Stock a Good Buy Now?

Biotech News | 02.06.2020

The American biopharmaceutical company Radius Health is based out of Waltham (MA). Radius is...

Aveo Oncology Biotech News

Important Week Ahead for the Aveo Oncology Stock: +/- 400% on Friday?

Biotech News | 24.05.2020

This week is of critical importance for Aveo Oncology. The American company will present the final...

Biotech Vir Biotechnology

Why Vir Biotech’s Stock Price Is Skyrocketing: +32.1% Today!

Biotech News | 18.05.2020

Shares of Vir Biotechnology jumped by more than 32% today after the company announced promising...

Biotech News

Biotech Mergers and Acquisitions: Top Takeover Targets for 2020 – News, Rumors, What Is Next?

Biotech News | 17.05.2020

Mergers and acquisitions in biotech industry often result in a big fat premium for stock owners. In...

Biotech Intra-Cellular Therapies News

Biotech Hot Stock Intra-Cellular Therapies: The Next Takeover Target and Buyout Candidate for 2020?

Biotech News | 11.05.2020

Biotech experts are used to the never-ending merger and aquisition rumors in the news. Most of them...

Biotech News

Top Biotech Takeover Targets for 2020: Are These The Best Stocks to Buy Now?

Biotech News | 05.05.2020

More than 25 merger and acquisitions have been executed in the biotech sector in 2019. The volume...

Aveo Oncology Biotech News

Top Stock Speculative: Aveo Oncology, +25% Today!

Biotech News | 30.04.2020

Aveo Oncology’s stock shows a massive buy signal after the company has announced that the final...

Biotech Capricor Therapeutics News

Stock Alert: Why Does Capricor Therapeutics’ Share Jump 252% Today?

Biotech News | 29.04.2020

Shares of the California-based biotech Capricor Therapeutics skyrocket by more than 252% on...

Biotech Idorisa Pharmaceuticals News

Idorsia Stock Explodes After Insomnia Drug Hits Primary Endpoint in Phase 3 Trial

Biotech News | 21.04.2020

Shares of the Swiss biotech Idorisa increase by more than 13% after the company has announced that...

Biotech News Vir Biotechnology

Vir Biotechnology Identifies Two Antibodies with Therapeutic Potential for COVID-19

Biotech News | 25.03.2020

The US biotech Vir Biotechnology announced it will proceed with two antibodies with the potential...

Biotech News Novavax

This Is the Reason Why Novavax’ Stock Is Skyrocketing: +6.3% Today!

Biotech News | 10.03.2020

In addition to suppliers of medical equipment such as respiratory masks or other protective...

Alnylam Pharmaceuticals Biotech News Vir Biotechnology

Alnylam and Vir Expand Collaboration to Develop RNAi Therapeutics for Coronavirus Infection

Biotech News | 06.03.2020

Alnylam Pharmaceuticals and Vir Biotechnology expand their collaboration to advance siRNA...

Biotech News Sangamo Therapeutics

Sangamo Therapeutics: $2.7 Billion Deal with Biogen for Neurodegenerative Disorders

Biotech News | 02.03.2020

Sangamo Therapeutics and Biogen announced a global licensing collaboration deal for the development...

Biotech GW Pharmaceuticals TOP PICK

GW Pharmaceuticals: One of the Top Biotech Stocks for 2020

Biotech News | 26.02.2020

In the period of May to December 2019, shares of GW Pharmaceuticals had to suffer a major setback...

Biotech Esperion Therapeutics News

FDA Approves Esperion’s Cholesterol-Lowering Drug Nexletol

Biotech News | 25.02.2020

The US Food and Drug Administration approves Esperion’s oral LDL-Cholesterol (LDL-C) lowering...

AB Science Biotech News

AB Science With Positive Trial in Progressive Forms of Multiple Sclerosis

Biotech News | 23.02.2020

Last Thursday, AB Science announced positive top-line results of a phase 2B/3 trial for oral...

Biotech Incyte News

Incyte With Second Positive Pivotal Trial in Atopic Dermatitis (Eczema)

Biotech News | 19.02.2020

Incyte today announced that also the second of two identical phase 3 trials with Ruxolitinib cream...

Biotech Esperion Therapeutics News

Esperion Therapeutics: Important Days Ahead!

Biotech News | 18.02.2020

The next two weeks are of critical importance for the US pharmaceutical company Esperion...

Allied Healthcare Products Biotech

This Is the Reason Why Genprex’s Stock Soars: +56% Today!

Biotech News | 14.02.2020

Genprex stock surges on Friday: +56%. But what is the reason for this massive increase? The...

Biotech Eli Lilly News Roche

Severe Setback on the Way Towards a Therapy for Alzheimer’s Disease

Biotech News | 11.02.2020

Roche and Eli Lilly announced that their anti-amyloid beta antibodies failed a phase 2/3 clinical...

Biotech GW Pharmaceuticals News

GW Pharmaceuticals Jumps 7%: Is Now the Time to Buy this Stock?

Biotech News | 08.02.2020

Shares of GW Pharmaceuticals, a global leader in cannabinoid-based medicines and member of our...

Aimmune Therapeutics Biotech News

FDA Approves First Treatment for Peanut Allergy

Biotech News | 03.02.2020

Good news for millions of people worldwide suffering from an allergy to peanuts. The FDA approves...

Biotech Incyte News

Incyte With Second Positive Phase 3 Trial in Atopic Dermatitis Within Two Days

Biotech News | 28.01.2020

These are truly exciting days for Incyte. The American biopharmaceutical company and member of our...

Biotech Eli Lilly Incyte News

Eli Lilly and Incyte’s Olumiant Clears Pivotal Trial in Atopic Dermatitis

Biotech News | 27.01.2020

Incyte and Eli Lilly today announced the results from a phase 3 clinical trial with Olumiant...

Allied Healthcare Products Biotech

Why Does Allied Healthcare Products’ Share Soar? +93% Today!

Biotech News | 24.01.2020

Shares of Allied Healthcare Products were surging on Friday by more than 93%. But what is the...

Biotech Myovant Sciences News

Myovant Sciences: One of the Takeover Targets in Biotech Industry for 2020

Biotech News | 24.01.2020

More than 25 mergers and acquisitions have been executed in biotech industry in 2019. It is...

Biotech Hutchinson China Meditech News

Hutchison China Meditech Stops Phase 3 Trial in Pancreatic Cancer Upon Early Success

Biotech News | 21.01.2020

Hutchison China Meditech, also known as Chi-Med, has terminated a phase 3 clinical trial with...

Biotech Lonza News

Lonza Group’s Share Jumps: Higher Profit and Focus on Biotech

Biotech News | 21.01.2020

The Swiss Lonza Group, a leading supplier to the pharmaceutical and biotech industry and member of...

Biotech Evotec News

Evotec Exceeds Expectations: The Specialist for Biologics Is on Track

Biotech News | 20.01.2020

Thanks to good business in the fourth quarter and unexpectedly high milestone payments, the...

Biotech Clovis Oncology News

Clovis Oncology: One of the Takeover Targets in Biotech Industry for 2020

Biotech News | 17.01.2020

The biotech industry is well-known for its merger and acquisition activities and a lot of takeover...

Astellas Audentes Therapeutics Biotech News

Astellas Pharma Completes Acquisition of Audentes Therapeutics

Biotech News | 15.01.2020

Astellas Pharma today announced that it has successfully completed the planned acquisition of...

Biotech Deciphera Pharmaceuticals News

One of the Top Biotech Takeover Targets for 2020: Deciphera Pharmaceuticals

Biotech News | 15.01.2020

Major merger and acquisition activities in the biotech industry can most likely also be expected...

Biotech News

Biotech Investments Model Portfolio: +26.1% in 2019!

Biotech News | 31.12.2019

The year 2019 was once again a very successful one. The performance of the Biotech Investments...

Biotech News Qiagen

Qiagen Stock Crashes: Company Rebuffs all Takeover Offers

Biotech News | 28.12.2019

Qiagen decided to stay alone After multiple takeover offers over the past few months, the company...

Biotech Intercept Pharmaceuticals News

Is 2020 Going to Be the Year for the First Approved Treatment for the Fatty Liver Disease NASH?

Biotech News | 22.12.2019

Nonalcoholic steatohepatitis (NASH) is a modern lifestyle condition which is mainly driven by...

Biogen Biotech Ionis Pharmaceuticals News

Biogen Continues to Search for a Breakthrough in Alzheimer’s: 45 Million for Ionis’ Phase 1 Drug

Biotech News | 19.12.2019

Biogen hasn’t resigned yet in the search for a major breakthrough in Alzheimer’s disease. The...

Biotech Macrogenics News

Macrogenics Submits Biologics License Application for Margetuximab to FDA

Biotech News | 19.12.2019

Macrogenics, the US oncology company and member of our Biotech Investments Model Portfolio, today...

Agios Pharmaceuticals Biotech News

Agios Pharmaceuticals: FDA Breakthrough Therapy Designation for Tibsovo in Myelodysplastic Syndrome

Biotech News | 18.12.2019

Agios Pharmaceuticals’ cancer drug Tibsovo is granted FDA breakthrough therapy designation for...

Alnylam Pharmaceuticals Biotech News

Alnylam Reports Positive Phase 3 Results for its ILLUMINATE-A Trial of Lumasiran in Primary Hyperoxaluria

Biotech News | 17.12.2019

The US biotech company and specialist in RNA interference therapies Alnylam Pharmaceuticals today...

Biotech News Sarepta Therapeutics

Sarepta: Share Price Explosion after FDA Hammer! And now?

Biotech News | 15.12.2019

There is only one suitable word for yesterdays’ news: sensation! The American healthcare...

Audentes Therapeutics Biotech News

Astellas Pharma to Buy Audentes for $3 Billion: +270 since January 2019%!

Biotech News | 02.12.2019

We have to say goodbye to our Biotech Investments Model Portfolio member Audentes Therapeutics. The...

Biotech News

Biotech Investments Model Portfolio: +23.1% as of November 30!

Biotech News | 01.12.2019

Biotech Investments' Model Portfolio performance is +23.1% as of November 30. This corresponds to...

Biotech Corbus Pharmaceuticals News

Corbus Pharmaceuticals Presents Phase 2 OLE Data for Lenabasum: Is This Stock a Buy Now?

Biotech News | 11.11.2019

Corbus Pharmaceuticals today presented the open-label-extension (OLE) data from its two phase 2...

Biotech News Science and Medicine Vertex Pharmaceuticals

Vertex Pharmaceuticals and Trikafta: Hope for Patients With Cystic Fibrosis

Biotech News | 10.11.2019

  The US Food and Drug Administration FDA has approved a drug against cystic fibrosis that...

Biotech Evotec News Vifor Pharmaceuticals

Evotec and Vifor Pharmaceuticals with Joint Venture for New Nephrology Drugs

Biotech News | 10.11.2019

Evotec and Vifor Pharmaceuticals today announced a joint venture for the development of drugs for...

Biotech Incyte News

Incyte Opts for Switzerland as its New European Headquarters

Biotech News | 10.11.2019

The American biotech company Incyte has chosen the Swiss city Morges as its European headquarters....

Biotech Esperion Therapeutics News

Esperion Therapeutics to Present Pooled Analyses from its Phase 3 Trials with Bempedoic Acid at AHA Congress

Biotech News | 04.11.2019

Esperion Therapeutics today announced that it will present a pooled analysis of its 4 phase 3...

Aveo Oncology Biotech

This Is the Reason Why Aveo Oncology’s Share Plunges: -36%!

Biotech News | 04.11.2019

Shares of Aveo Oncology are down more than 36% to $0.57 today. But what is the reason for this...

Amgen BeiGene Biotech News

Hammer Deal: Amgen Joins Model Portfolio Member BeiGene – Share Explodes 37 Percent!

Biotech News | 01.11.2019

The biotech giant Amgen wants to increase its presence in China. The Americans will buy 20.5% of...

Biotech News

Biotech Investments Model Portfolio: +4.1% as of October 31

Biotech News | 31.10.2019

Biotech Investments' Model Portfolio performance is +4.1% as of October 31. This corresponds to an...

Biotech CRISPR Therapeutics News Vertex Pharmaceuticals

Takeover Rumors about CRISPR Therapeutics: Does Vertex Make a Move?

Biotech News | 30.10.2019

As a result of new takeover rumors, CRISPR Therapeutics’ share price has increased more than 27%...

Biotech Macrogenics News

Pfizer Stops Collaboration with Macrogenics on a Bispecific Antibody for Solid Tumors

Biotech News | 29.10.2019

Macrogenics has to digest a severe setback as Pfizer plans to stop a collaboration on a bispecific...

Biotech Morphosys News

Morphosys, Galapagos and Novartis to Shut Down Atopic Dermatitis Program

Biotech News | 29.10.2019

Morphosys, Galapagos, and Novartis have to accept a severe setback with their clinical trial...

Biotech News Polyphor

Polyphor Identifies New Class of Antibiotics: Stock Explodes!

Biotech News | 24.10.2019

Researchers from the Swiss biotech company Polyphor and the University of Zurich have presented the...

BioNTech Biotech News

BioNTech: Is This Stock a Buy Now?

Biotech News | 23.10.2019

The stock of BioNTech has gone through a real rally since its IPO on October 10. From Tuesday,...

Biotech Macrogenics News

Macrogenics Stocks Down 15% after Presentation of Updated Survival Data for Margetuximab

Biotech News | 23.10.2019

Shares of the Biotech Investments Model Portfolio member Macrogenics are down 15% to $9.38 today...

Biogen Biotech

This Is the Reason why Biogen’s Share Explodes: +27% Today!

Biotech News | 22.10.2019

Biogen’s stock rockets 27% to $284.86 today. But what is the reason for this explosion? Is...

Biotech News Seattle Genetics

Seattle Genetics Stock Jumps after Positive Trial Results with ErbB-2 Inhibitor Tucatinib

Biotech News | 22.10.2019

Seattle Genetics was one of the main winners of this year's ESMO congress. The company's shares...

Alexion Pharmaceuticals Biotech News

FDA Approves Alexion’s Ravulizumab for Atypical Hemolytic Uremic Syndrome

Biotech News | 19.10.2019

The US healthcare authority FDA on Friday approved Alexion Pharmaceuticals’ drug Ravulizumab for...

Alexion Pharmaceuticals Biotech News

Alexion with $930 Million Takeover of Achillion Pharmaceuticals to Expand Drug Pipeline for Rare Immunological Diseases

Biotech News | 16.10.2019

The big merger and acquisition (M&A) wave in biotech industry continues. Alexion...

Biotech News Relmada Therapeutics

This is the Reason why Relmada Therapeutics’ Share Explodes: +143% Today!

Biotech News | 15.10.2019

Relmada Therapeutics stock rockets 143% to $27.01 today. But what is the reason for this...

Biotech Incyte News

Incyte’s Ruxolitinib Cream with Positive Phase 2 Trial in Vitiligo

Biotech News | 14.10.2019

A phase 2 clinical trial with Incyte’s Ruxolitinib cream in patients with vitiligo met its...

Biotech Ionis Pharmaceuticals News

Bayer Advances with Ionis’ Factor XI Anti-Thrombotic Drug

Biotech News | 09.10.2019

Ionis Pharmaceuticals, a leader in antisense therapy with a pipeline of more than 40 drug...

BioNTech Biotech News

BioNTech IPO: a Good Deal for Investors?

Biotech News | 09.10.2019

The German biotech company BioNTech is one of the hot players in the field of flu vaccine...

Akcea Therapeutics Biotech News

This is the Reason why Akcea Therapeutics’ Share Explodes: +35% Today!

Biotech News | 07.10.2019

Shares of Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals and member of our Biotech...

Biotech Deciphera Pharmaceuticals News

Deciphera Pharmaceuticals: One of the Top Takeover Targets in Biotech Industry?

Biotech News | 02.10.2019

Deciphera Pharmaceuticals, a Waltham (Massachusetts)-based specialist for precision oncology, is...

Biotech News Sangamo Therapeutics

Sangamo Therapeutics Hires New Chief Medical Officer

Biotech News | 01.10.2019

Sangamo today announced Bettina Cockroft as a new chief medical offier for its gene editing...

Biotech News Vertex Pharmaceuticals

Vertex Pharmaceuticals Appoints Carmen Bozic as New Chief Medical Officer

Biotech News | 01.10.2019

Vertex Pharmaceuticals' today announced Carmen Bozic as a successor of the previous chief medical...

Biotech Hutchinson China Meditech News

CK Hutchison Offers 1.3% of Hutchison China Meditech’s Share Capital

Biotech News | 30.09.2019

Hutchison China Meditech Limited, also known as Chi-Med, today announced in London that its...

Agios Pharmaceuticals Biotech News

Agios’ Drug Tibsovo Prolongs Progression-Free Survival in Phase 3 Cholangiocarcinoma Trial by only 2 Months, Shares Down by 6%

Biotech News | 30.09.2019

Agios Pharmaceuticals today announced the presentation of phase 3 clinical trial data for Tibsovo....

Biotech Macrogenics News

Macrogenics Presents Updated Analysis of its Phase 2 Trial with Margetuximab in Metastatic Gastroesophageal Cancer: Share Gains more than 4%

Biotech News | 30.09.2019

Macrogenics, a US biotechnology company focusing on the development of novel antibody therapies for...

Biotech News

Biotech Investments Model Portfolio: +3.1% as of September 29

Biotech News | 29.09.2019

The Performance of Biotech Investments Model Portfolio is +3.1% as of September 29. After a...

Biotech Incyte News

Incyte with Positive Results from Phase 2 Trial of Pemigatinib in Advanced Cholangiocarcinoma

Biotech News | 27.09.2019

The US pharmaceutical company Incyte, a member of our Biotech Investments Model Portfolio which is...

Biotech Jazz Pharmaceuticals News

Jazz Pharmaceuticals Announces Positive Phase 3 Data for Narcolepsy

Biotech News | 26.09.2019

JZP-258, a novel oxybate product candiadate by Jazz Pharmaceutials, was successfully tested in a...

Biotech Incyte News

Incyte Announces Successful Initiation of Phase 3 Program with Ruxolitinib Cream for Patients with Vitiligo

Biotech News | 25.09.2019

The US pharmaceutical company Incyte today released an announcement saying that the phase 3...

Biotech Evotec News

Evotec and Takeda Agree on a Deal for Drug Discovery

Biotech News | 24.09.2019

The Hamburg-based biotech company Evotec which offers services to partners such as Sanofi or Bayer...

Akcea Therapeutics Biotech News

Akcea Therapeutics Appoints Damien McDevitt as Interim CEO

Biotech News | 23.09.2019

Akcea Therapeutics, a Cambridge-based affiliate of Ionis Pharmaceuticals specialized on the...

Biotech Five Prime Therapeutics News

Five Prime Therapeutics CEO Aron Knickerbocker is Leaving the Company

Biotech News | 20.09.2019

Aron Knickerbocker, CEO of the San Francisco-based immune-oncology firm Five Prime Therapeutics, is...

AIM ImmunoTech Biotech News

This Is the Reason why AIM ImmunoTech’s Share Explodes: +46% Today!

Biotech News | 19.09.2019

Shares of AIM ImmunoTech, a small company from Philadelphia engaged in the clinical development of...

Biotech News Vertex Pharmaceuticals

Quo Vadis, Vertex Pharmaceuticals?

Biotech News | 18.09.2019

The Boston-based US biopharmaceutical company Vertex Pharmaceuticals, specialized in the treatment...

Biotech News Zynerba Pharmaceuticals

Zynerba Pharmaceuticals Reports Positive Topline Data from a Phase 2 Study of its CBD Gel Treatment Zygel in Patients with Encephalopathies

Biotech News | 18.09.2019

Zynerba Pharmaceuticals, a small US company specialized on next-generation cannabinoid therapeutics...

Aclaris Therapeutics Biotech News

This Is the Reason why Aclaris Therapeutics’ Share Explodes: +52% Today!

Biotech News | 17.09.2019

Shares of Aclaris Therapeutics, a physician-led biopharmaceutical company committed to the...

Biotech CRISPR Therapeutics News

CRISPR Therapeutics and ViaCyte Present Promising In-Vitro Data Towards a Potential Diabetes Cure

Biotech News | 17.09.2019

CRISPR Therapeutics, a company specialized on gene therapies for severe diseases using a...

Alder Biopharmaceuticals Biotech News

This Is the Reason Why Alder Biopharmaceutials’ Share Explodes: +83% Today!

Biotech News | 16.09.2019

Shares of Alder Biopharmaceuticals are up by 83% to $18.42 after the Danish pharmaceutical company...

Alnylam Pharmaceuticals Biotech News

Alnylam Pharmaceuticals Initiates New Phase 3 Trial of Patisiran for the Treatment of Patients with Transthyretin Amyloidosis with Cardiomyopathy

Biotech News | 16.09.2019

Alnylam Therapeutics, a leading RNA interference company and member of our Biotech Investments...

Akcea Therapeutics Biotech News

Akcea Therapeutics Presents Positive Phase 1 Results for its Transthyretin Amyloidosis Drug AKCEA-TTR-LRx

Biotech News | 16.09.2019

The Boston-based US biotechnology company Akcea Therapeutics today presented positive results of a...

Biotech News

Alnylam Pharmaceuticals Adds an Additional Piece of Evidence to the Pathogenic Role of the V122I Mutation of Transthyretin

Biotech News | 13.09.2019

The Cambridge-based US biopharmaceutical company Alnylam Pharmaceuticals, a market leader in RNA...

Biotech Fibrocell Science News

This Is the Reason why Fibrocell Science’s Share Explodes: +60% Today!

Biotech News | 13.09.2019

Shares of the US biotech company Fibrocell Science skyrocketed today after the specialist for cell...

Biotech News Tocagen

This Is the Reason Why Tocagen’s Share Plunges: -78% Today!

Biotech News | 12.09.2019

Shares of San Diego-based biotech company Tocagen have plunged more than 78% today after the...

Adverum Biotechnologies Biotech News

This Is the Reason Why Adverum Biotechnologies’ Share Plunges: -50% Today!

Biotech News | 12.09.2019

Shares of Adverum Biotechnologies are down 50% to $6.00 after the presentation of positive 24-week...

Biotech News

BioSpace Article on the Top Takeover Targets: 4 out of 10 Companies Are Part of the Biotech Investments Model Portfolio

Biotech News | 11.09.2019

BioSpace, a mouthpiece for news from the biotech industry, today released an interesting article on...

Aveo Oncology Biotech News

AVEO Oncology Announces Updated Overall Survival Data of its Phase 3 TIVO-3 Trial of Tivozanib in Patients with Renal Cell Carcinoma, Stock Jumps by 40%

Biotech News | 10.09.2019

The Cambridge-based US biopharmaceutical company AVEO Oncology today announced the results from the...

BeiGene Biotech News

BeiGene Has to Defend Against Short Report, Share Plunges

Biotech News | 10.09.2019

BeiGene, the outstanding example of the fast-developing Chinese biotech industry and member of the...

Acadia Pharmaceuticals Biotech News

This Is the Reason Why Acadia Pharmaceuticals’ Share Explodes: +63% Today!

Biotech News | 09.09.2019

Shares of Acadia Pharmaceuticals today rocketed 63% after the San Diego-based biopharmaceutical...

Biotech News Polyphor

Polyphor Share Price Jumps by 30% After CEO Statements

Biotech News | 09.09.2019

Shares of the Swiss biotech company Polyphor jump at the beginning of this week. Reason being the...

Biotech Edesa Biotech News

Edesa Shares Jump After Health Canada Approval to Begin Clinical Trial in Patients with Hemorrhoids

Biotech News | 06.09.2019

The stock of Edesa biotech jumps in response to Health Canada's decision to approve a clinical...

Biotech Neon Therapeutics News

This Is the Reason Why Neon Therapeutics’ Share Explodes: +40% Today!

Biotech News | 06.09.2019

Shares of Neon Therapeutics, a leader in the field of neoantigen-targeted therapies which tries to...

Biotech News

Biotech Investments Model Portfolio: +14.8% as of August 31

Biotech News | 05.09.2019

The Performance of Biotech Investments Model Portfolio is +14.8% as of August 31. Although this...

Biotech Cidara Therapeutics News

This Is the Reason Why Cidara Therapeutics’ Share Explodes: +40% Today!

Biotech News | 03.09.2019

Shares of Cidara Therapeutics, a US biotechnology company developing novel anti-infectives and...

Abeona Therapeutics Biotech News

This Is the Reason Why Abeona Therapeutics’ Share Explodes: +108% Today!

Biotech News | 03.09.2019

Abeona Therapeutics, a US biotechnology company specialized in the development of gene and cell...

Biotech News Vertex Pharmaceuticals

Vertex Pharmaceuticals Pays $950 Million for Stem Cell Player Semma Therapeutics

Biotech News | 03.09.2019

Vertex Pharmaceuticals, the US cystic fibrosis specialist and member of our Biotech Investments...

Biotech Esperion Therapeutics News

Esperion’s Cholesterol-Lowering Drug Bembedoic Acid With Positive Top-Line Results from Phase 2 Trial in Patients with Type 2 Diabetes

Biotech News | 29.08.2019

Esperion Therapeutics, a US-based pharmaceutical company specialized in the development of oral...

Biotech Kezar Life Sciences News

Kezar Life Sciences Share still under Strong Pressure

Biotech News | 27.08.2019

Kezar Life Sciences is currently still in a difficult position on the stock exchange. The...

Alexion Pharmaceuticals Biotech News

Takeover Rumors Boost Alexion Pharmaceuticals Share

Biotech News | 23.08.2019

The share price of our sample portfolio member Alexion Pharmaceuticals exploded this week. The...

Biotech News Sarepta Therapeutics

Sarepta Therapeutics: FDA Refuses Marketing Approval for Duchenne Drug Golodirsen

Biotech News | 19.08.2019

The gene therapy powerhouse Sarapta Therapeutics and member of our Model Portfolio has to digest...

Biotech News Roche

Roche Receives FDA Approval for Cancer Drug Rozlytrek

Biotech News | 16.08.2019

Roche, the Basel-based pharmaceutical company, announced this morning that it has received approval...

Biotech Evotec News

Evotec Publishes Convincing Half-Yearly Results, Share Plunges

Biotech News | 15.08.2019

Despite the announcement of convincing half-year results and an increase in the forecast for 2019...

Biotech News Santhera Pharmaceuticals

Santhera CFO Christoph Rentsch Leaves the Company, Share Loses More than 6%

Biotech News | 15.08.2019

Santhera today announced in a press release that there has been a change in management. CFO...

Akari Therapeutics Biotech News

This Is the Reason Why Akari Therapeutics’ Share Explodes: +61% Today!

Biotech News | 14.08.2019

The shares of the English biopharmaceutical company Akari Therapeutics, which specializes in the...

Biotech Deciphera Pharmaceuticals News

This Is the Reason Why Deciphera Pharmaceuticals’ Share Explodes: +80% Today!

Biotech News | 13.08.2019

Deciphera Pharmaceuticals announced today that its Phase 3 INVICTUS study with Ripretinib in...

Biotech News Sarepta Therapeutics

Sarepta after Drop in Share Price: CEO Ingram Now Buys on a Grand Scale

Biotech News | 13.08.2019

After a patient developed a severe side effect in a gene therapy study, the Sarepta share price...

Biotech News Sarepta Therapeutics

Sarepta Comments on Incorrect Submission to FDA’s FEARS Adverse Events Reporting System

Biotech News | 08.08.2019

Sarepta Therapeutics, a leading provider of gene therapy for rare diseases and a member of our...

Audentes Therapeutics Biotech News

Audentes Therapeutics Publishes Business and Pipeline Update for Second Quarter 2019

Biotech News | 06.08.2019

Audentes Therapeutics, a member of our Model Portfolio specializing in the development of gene...

Agios Pharmaceuticals Biotech News

Encouraging Second Quarter for Agios Pharmaceuticals: IDH inhibitor Tibsovo Shows Strong Growth

Biotech News | 01.08.2019

Agios Pharmaceuticals, a company specializing in the development of oncology and rare genetic...

Biotech News Vertex Pharmaceuticals

Vertex Pharmaceuticals Increases Sales by 25% in the Second Quarter of 2019

Biotech News | 01.08.2019

Vertex Pharmaceuticals yesterday evening announced its financial results for the second quarter of...

Biotech Macrogenics News

Macrogenics Publishes Business and Pipeline Update for the Second Quarter of 2019, Share Price Falls Slightly

Biotech News | 31.07.2019

Our Model Portfolio member Macrogenics, which specializes in the development of innovative antibody...

Biotech Incyte News

Model Portfolio Member Incyte Increases Turnover in the Second Quarter, Share Price Rises 6%

Biotech News | 30.07.2019

Our sample portfolio value Incyte today presented its annual report for the second quarter of 2019...

Biotech News

Biotech Investments Model Portfolio: +26.7% as of 28 July 2019

Biotech News | 28.07.2019

The Model Portfolio of Biotech Investments developed extremely positively in the first seven months...

Biotech News Solid Biosciences

Solid Biosciences Share Rises by more than 30%!

Biotech News | 26.07.2019

Solid Biosciences' share price today rose by over 30%. This is due to a private placement of 10.6...

Biotech News Pluristem Therapeutics

This Is the Reason why Pluristem Therapeutics’ Share Explodes: +1000% Today!

Biotech News | 25.07.2019

Pluristem Therapeutics, a leading provider of regenerative medicine, which develops placenta-based...